{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:40:05Z","timestamp":1792431605647,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-026-00457-3","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:33:10Z","timestamp":1784741590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of eHealth lifestyle interventions on management of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4957-8135","authenticated-orcid":false,"given":"Yangguo","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy Ngo Sheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8170-432X","authenticated-orcid":false,"given":"Caixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"457_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.jhep.2023.09.038","volume":"81","author":"K Cusi","year":"2024","unstructured":"Cusi K, Younossi Z, Roden M. From NAFLD to MASLD: promise and pitfalls of a new definition. J Hepatol. 2024;81:e18\u2013e19.","journal-title":"J Hepatol"},{"key":"457_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S32\u2013s50.","journal-title":"Clin Mol Hepatol"},{"key":"457_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1624440","volume":"12","author":"Y Tang","year":"2025","unstructured":"Tang Y, Gu C. Epidemiological transition of metabolic dysfunction-associated steatotic liver disease-related chronic liver disease and cirrhosis: a comparative study between China and the global population (1990-2021). Front Nutr. 2025;12:1624440.","journal-title":"Front Nutr"},{"key":"457_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u2013S64.","journal-title":"J Hepatol"},{"key":"457_CR5","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.cgh.2023.01.006","volume":"21","author":"L de Avila","year":"2023","unstructured":"de Avila L, Henry L, Paik JM, Ijaz N, Weinstein AA, Younossi ZM. Nonalcoholic fatty liver disease is independently associated with higher all-cause and cause-specific mortality. Clin Gastroenterol Hepatol. 2023;21:2588\u201396.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"457_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"457_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","volume":"20","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Zelber-Sagi S, Henry L, Gerber LH. Lifestyle interventions in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2023;20:708\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"457_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","volume":"57","author":"SE Keating","year":"2012","unstructured":"Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;57:157\u201366.","journal-title":"J Hepatol"},{"key":"457_CR9","first-page":"Cd013156","volume":"6","author":"E Buzzetti","year":"2021","unstructured":"Buzzetti E, Linden A, Best LM, Madden AM, Roberts D, Chase TJG, et al. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;6:Cd013156.","journal-title":"Cochrane Database Syst Rev"},{"key":"457_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.metabol.2016.12.006","volume":"68","author":"CN Katsagoni","year":"2017","unstructured":"Katsagoni CN, Georgoulis M, Papatheodoridis GV, Panagiotakos DB, Kontogianni MD. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis. Metabolism. 2017;68:119\u201332.","journal-title":"Metabolism"},{"key":"457_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.011","volume":"15","author":"C Arora","year":"2021","unstructured":"Arora C, Malhotra A, Ranjan P, Vikram NK, Dwivedi SN, Singh N, et al. Perceived barriers and facilitators for adherence to lifestyle prescription: perspective of obese patients with non alcoholic fatty liver disease from north India. Diabetes Metab Syndr. 2021;15:102138.","journal-title":"Diabetes Metab Syndr"},{"key":"457_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2185\/jrm.2023-026","volume":"19","author":"K Shibayama","year":"2024","unstructured":"Shibayama K, Furushima C, Saka M, Sakamoto T, Takahashi H. Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping review. J Rural Med. 2024;19:1\u20139.","journal-title":"J Rural Med"},{"key":"457_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367\u201378.e5.","journal-title":"Gastroenterology"},{"key":"457_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/liv.13622","volume":"38","author":"P Axley","year":"2018","unstructured":"Axley P, Kodali S, Kuo YF, Ravi S, Seay T, Parikh NM, et al. Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: a randomized study. Liver Int. 2018;38:924\u201331.","journal-title":"Liver Int"},{"key":"457_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep36783","volume":"6","author":"F Dong","year":"2016","unstructured":"Dong F, Zhang Y, Huang Y, Wang Y, Zhang G, Hu X, et al. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep. 2016;6:36783.","journal-title":"Sci Rep"},{"key":"457_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.eprac.2023.08.016","volume":"29","author":"S Joshi","year":"2023","unstructured":"Joshi S, Shamanna P, Dharmalingam M, Vadavi A, Keshavamurthy A, Shah L, et al. Digital twin-enabled personalized nutrition improves metabolic dysfunction-associated fatty liver disease in type 2 diabetes: results of a 1-year randomized controlled study. Endocr Pract. 2023;29:960\u201370.","journal-title":"Endocr Pract"},{"key":"457_CR17","doi-asserted-by":"publisher","first-page":"e00806","DOI":"10.14309\/ctg.0000000000000806","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J, Zhao J, Zhong Y, He C, Hu F. Healthy lifestyle and metabolic dysfunction-associated steatotic liver disease: a study of the efficacy of fatty liver regression. Clin Transl Gastroenterol. 2025;16:e00806.","journal-title":"Clin Transl Gastroenterol"},{"key":"457_CR18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jhep.2018.07.013","volume":"69","author":"A Mazzotti","year":"2018","unstructured":"Mazzotti A, Caletti MT, Brodosi L, Di Domizio S, Forchielli ML, Petta S, et al. An internet-based approach for lifestyle changes in patients with NAFLD: two-year effects on weight loss and surrogate markers. J Hepatol. 2018;69:1155\u201363.","journal-title":"J Hepatol"},{"key":"457_CR19","doi-asserted-by":"publisher","first-page":"e49839","DOI":"10.2196\/49839","volume":"26","author":"OY Kwon","year":"2024","unstructured":"Kwon OY, Lee MK, Lee HW, Kim H, Lee JS, Jang Y. Mobile app-based lifestyle coaching intervention for patients with nonalcoholic fatty liver disease: randomized controlled trial. J Med Internet Res. 2024;26:e49839.","journal-title":"J Med Internet Res"},{"key":"457_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cgh.2023.08.033","volume":"22","author":"N Pugliese","year":"2024","unstructured":"Pugliese N, Wai-Sun Wong V, Schattenberg JM, Romero-Gomez M, Sebastiani G, Aghemo A. Accuracy, reliability, and comprehensibility of ChatGPT-generated medical responses for patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2024;22:886\u20139.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"457_CR21","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.14309\/ajg.0000000000002143","volume":"118","author":"M Sato","year":"2023","unstructured":"Sato M, Akamatsu M, Shima T, Ikegami T, Yanase M, Mikami S, et al. Impact of a novel digital therapeutics system on nonalcoholic steatohepatitis: the NASH app clinical trial. Am J Gastroenterol. 2023;118:1365\u201372.","journal-title":"Am J Gastroenterol"},{"key":"457_CR22","first-page":"108","volume":"24","author":"J Li","year":"2018","unstructured":"Li J, He TS, Wang P, Zhang ZL, Ouyang YL, Huang YY, et al. The Application of the PDCA health education management model on the Wechat platform in patients with fatty liver. J Qilu Nurs. 2018;24:108\u201310.","journal-title":"J Qilu Nurs"},{"key":"457_CR23","doi-asserted-by":"crossref","unstructured":"Ghodsbin F, Javanmardifard S, Javad Kaviani M, Jahanbin I. Effect of tele-nursing in the improving of the ultrasound findings in patients with nonalcoholic fatty liver diseases: a randomized clinical trial study. Investig Educ Enferm. 2018;36:3.","DOI":"10.17533\/udea.iee.v36n3e09"},{"key":"457_CR24","first-page":"239","volume":"4","author":"SJ Fard","year":"2016","unstructured":"Fard SJ, Ghodsbin F, Kaviani MJ, Jahanbin I, Bagheri Z. The effect of follow up (telenursing) on liver enzymes in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery. 2016;4:239\u201346.","journal-title":"Int J Community Based Nurs Midwifery"},{"key":"457_CR25","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/liv.16025","volume":"44","author":"HY Yuan","year":"2024","unstructured":"Yuan HY, Tong XF, Ren YY, Li YY, Wang XL, Chen LL, et al. AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: an exploratory study. Liver Int. 2024;44:2572\u201382.","journal-title":"Liver Int"},{"key":"457_CR26","doi-asserted-by":"crossref","unstructured":"Cho E, Kim S, Kim S, Kim JY, Kim HJ, Go Y, et al. The effect of mobile lifestyle intervention combined with high-protein meal replacement on liver function in patients with metabolic dysfunction-associated steatotic liver disease: a pilot randomized controlled trial. Nutrients. 2024;16:2254.","DOI":"10.3390\/nu16142254"},{"key":"457_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10620-021-06922-6","volume":"67","author":"MA Tincopa","year":"2022","unstructured":"Tincopa MA, Lyden A, Wong J, Jackson EA, Richardson C, Lok AS. Impact of a pilot structured mobile technology based lifestyle intervention for patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2022;67:481\u201391.","journal-title":"Dig Dis Sci"},{"key":"457_CR28","doi-asserted-by":"publisher","first-page":"e37487","DOI":"10.2196\/37487","volume":"25","author":"OY Kwon","year":"2023","unstructured":"Kwon OY, Choi JY, Jang Y. The effectiveness of ehealth interventions on lifestyle modification in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis. J Med Internet Res. 2023;25:e37487.","journal-title":"J Med Internet Res"},{"key":"457_CR29","doi-asserted-by":"crossref","unstructured":"Zafar Y, Sohail MU, Saad M, Ahmed SZ, Sohail MO, Zafar J, et al. eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. BMJ Open Gastroenterol. 2025;12:e001670.","DOI":"10.1136\/bmjgast-2024-001670"},{"key":"457_CR30","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 2009;339:b2700.","journal-title":"Bmj"},{"key":"457_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"457_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"457_CR33","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898.","journal-title":"Bmj"},{"key":"457_CR34","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"457_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Brozek","year":"2009","unstructured":"Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64:669\u201377.","journal-title":"Allergy"},{"key":"457_CR36","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A. GRADE handbook. GRADE Working Group; 2013. GRADE Working Group. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 1 Apr 2026."},{"key":"457_CR37","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences 2nd edition ed. New York: 1988 13 May 2013.","DOI":"10.4324\/9780203771587"},{"key":"457_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137\u201359.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"457_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","volume":"350","author":"M Egger","year":"1997","unstructured":"Egger M, Zellweger-Z\u00e4hner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350:326\u20139.","journal-title":"Lancet"},{"key":"457_CR40","first-page":"1435","volume":"39","author":"Q Li","year":"2024","unstructured":"Li Q, Ma XE, Yang XX, He XX, Cai W. Application of self-management intervention scheme in patients with non-alcoholic fatty liver disease based on the integrated theory of health behavior change. J Nurses Train. 2024;39:1435\u201340.","journal-title":"J Nurses Train"},{"key":"457_CR41","doi-asserted-by":"publisher","first-page":"e086604","DOI":"10.1136\/bmjopen-2024-086604","volume":"15","author":"CL Freer","year":"2025","unstructured":"Freer CL, George ES, Tan SY, Abbott G, Paris T, Daly RM. Acceptability and perceptions of a 12-week telehealth exercise programme with dietary advice to increase plant-based protein in people with non-alcoholic fatty liver disease: a programme evaluation using mixed methods. BMJ Open. 2025;15:e086604.","journal-title":"BMJ Open"},{"key":"457_CR42","first-page":"1709","volume":"131","author":"CL Freer","year":"2024","unstructured":"Freer CL, George ES, Tan SY, Abbott G, Daly RM. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. Br J Nutr. 2024;131:1709\u201319.","journal-title":"Br J Nutr"},{"key":"457_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64988-4","volume":"14","author":"A Kaewdech","year":"2024","unstructured":"Kaewdech A, Assawasuwannakit S, Churuangsuk C, Chamroonkul N, Sripongpun P. Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial. Sci Rep. 2024;14:13961.","journal-title":"Sci Rep"},{"key":"457_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57722-7","volume":"14","author":"MA Tincopa","year":"2024","unstructured":"Tincopa MA, Patel N, Shahab A, Asefa H, Lok AS. Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease. Sci Rep. 2024;14:7452.","journal-title":"Sci Rep"},{"key":"457_CR45","doi-asserted-by":"publisher","first-page":"e14802","DOI":"10.2196\/14802","volume":"8","author":"SL Lim","year":"2020","unstructured":"Lim SL, Johal J, Ong KW, Han CY, Chan YH, Lee YM, et al. Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: randomized controlled trial. JMIR Mhealth Uhealth. 2020;8:e14802.","journal-title":"JMIR Mhealth Uhealth"},{"key":"457_CR46","doi-asserted-by":"crossref","unstructured":"Stine JG, Rivas G, Hummer B, Duarte-Rojo A, May CN, Geyer N, et al. Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH. Hepatol Commun. 2023;7\u2009e0052.","DOI":"10.1097\/HC9.0000000000000052"},{"key":"457_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.clnesp.2021.03.031","volume":"43","author":"S Policarpo","year":"2021","unstructured":"Policarpo S, Machado MV, Cortez-Pinto H. Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: a randomized controlled trial. Clin Nutr ESPEN. 2021;43:329\u201334.","journal-title":"Clin Nutr ESPEN"},{"key":"457_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18865-4","volume":"24","author":"N Dalal","year":"2024","unstructured":"Dalal N, Catalli L, Miller SA, Madan S, Tan R, Agudelo E, et al. BRIDGE to liver health: implementation of a group telehealth psychoeducational program through shared medical appointments for MASLD management. BMC Public Health. 2024;24:1546.","journal-title":"BMC Public Health"},{"key":"457_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.485","volume":"7","author":"SM Ang","year":"2024","unstructured":"Ang SM, Lim SL, Dan YY, Chan YH, Yap QV, Chen J. Clinical service incorporating mobile technology on weight loss in patients with metabolic dysfunction-associated steatotic liver disease: a translation from research trial. Endocrinol Diabetes Metab. 2024;7:e00485.","journal-title":"Endocrinol Diabetes Metab"},{"key":"457_CR50","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2169\/internalmedicine.56.8187","volume":"56","author":"T Aoyama","year":"2017","unstructured":"Aoyama T, Takada H, Uchiyama A, Kon K, Yamashina S, Ikejima K, et al. A customized online nutrition guidance system is effective for treating patients with nonalcoholic fatty liver disease by supporting continuity of diet therapy at home: a pilot study. Intern Med. 2017;56:1651\u20136.","journal-title":"Intern Med"},{"key":"457_CR51","doi-asserted-by":"publisher","first-page":"e20491","DOI":"10.2196\/20491","volume":"23","author":"K Hallsworth","year":"2021","unstructured":"Hallsworth K, McPherson S, Anstee QM, Flynn D, Haigh L, Avery L. Digital intervention with lifestyle coach support to target dietary and physical activity behaviors of adults with nonalcoholic fatty liver disease: systematic development process of vitalise using intervention mapping. J Med Internet Res. 2021;23:e20491.","journal-title":"J Med Internet Res"},{"key":"457_CR52","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i1.101630","volume":"17","author":"J Soni","year":"2025","unstructured":"Soni J, Pathak N, Gharia M, Aswal D, Parikh J, Sharma P, et al. Effectiveness of RESET care program: a real-world-evidence on managing non-alcoholic fatty liver disease through digital health interventions. World J Hepatol. 2025;17:101630.","journal-title":"World J Hepatol"},{"key":"457_CR53","doi-asserted-by":"publisher","first-page":"62 EP","DOI":"10.1016\/j.scispo.2022.10.007","volume":"39","author":"KK Gao","year":"2024","unstructured":"Gao KK, Li FH, Su YM, Wang J, Yu XM, Ruan L, et al. Impact of exercise intervention-based remote monitoring for patients with different grades of non-alcoholic fatty liver disease severity. Sci Sports. 2024;39:62 EP\u201362 71.","journal-title":"Sci Sports"},{"key":"457_CR54","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/apt.15427","volume":"50","author":"Y Huber","year":"2019","unstructured":"Huber Y, Pfirrmann D, Gebhardt I, Labenz C, Gehrke N, Straub BK, et al. Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. Aliment Pharmacol Ther. 2019;50:930\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"457_CR55","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s13300-024-01651-1","volume":"15","author":"AS Alexopoulos","year":"2024","unstructured":"Alexopoulos AS, Danus S, Parish A, Olsen MK, Batch BC, Thacker CR, et al. Intervening on metabolic dysfunction-associated steatotic liver disease in latino\/a and black patients with diabetes: a feasibility pilot. Diabetes Ther. 2024;15:2417\u201327.","journal-title":"Diabetes Ther"},{"key":"457_CR56","doi-asserted-by":"crossref","unstructured":"Petroni ML, Brodosi L, Armandi A, Marchignoli F, Bugianesi E, Marchesini G. Lifestyle intervention in NAFLD: long-term diabetes incidence in subjects treated by web- and group-based programs. Nutrients. 2023;15:792.","DOI":"10.3390\/nu15030792"},{"key":"457_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/apt.17768","volume":"59","author":"ML Petroni","year":"2024","unstructured":"Petroni ML, Colosimo S, Brodosi L, Armandi A, Bertini F, Montesi D, et al. Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting. Aliment Pharmacol Ther. 2024;59:249\u201359.","journal-title":"Aliment Pharmacol Ther"},{"key":"457_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gastha.2023.08.019","volume":"3","author":"N Alkhouri","year":"2024","unstructured":"Alkhouri N, Edwards K, Berman M, Finn H, Escandon R, Lupinacci P, et al. A novel prescription digital therapeutic option for the treatment of metabolic dysfunction-associated steatotic liver disease. Gastro Hep Adv. 2024;3:9\u201316.","journal-title":"Gastro Hep Adv"},{"key":"457_CR59","doi-asserted-by":"publisher","first-page":"e52576","DOI":"10.2196\/52576","volume":"8","author":"S Bj\u00f6rnsdottir","year":"2024","unstructured":"Bj\u00f6rnsdottir S, Ulfsdottir H, Gudmundsson EF, Sveinsdottir K, Isberg AP, Dobies B, et al. User engagement, acceptability, and clinical markers in a digital health program for nonalcoholic fatty liver disease: prospective, single-arm feasibility study. JMIR Cardio. 2024;8:e52576.","journal-title":"JMIR Cardio"},{"key":"457_CR60","doi-asserted-by":"publisher","first-page":"e30239","DOI":"10.2196\/30239","volume":"5","author":"V Motz","year":"2021","unstructured":"Motz V, Faust A, Dahmus J, Stern B, Soriano C, Stine JG. Utilization of a directly supervised telehealth-based exercise training program in patients with nonalcoholic steatohepatitis: feasibility study. JMIR Form Res. 2021;5:e30239.","journal-title":"JMIR Form Res"},{"key":"457_CR61","doi-asserted-by":"publisher","first-page":"e11250","DOI":"10.2196\/11250","volume":"21","author":"D Pfirrmann","year":"2019","unstructured":"Pfirrmann D, Huber Y, Schattenberg JM, Simon P. Web-based exercise as an effective complementary treatment for patients with nonalcoholic fatty liver disease: intervention study. J Med Internet Res. 2019;21:e11250.","journal-title":"J Med Internet Res"},{"key":"457_CR62","doi-asserted-by":"crossref","unstructured":"Albhaisi S, Tondt J, Cyrus J, Chinchilli VM, Conroy DE, Stine JG. Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. Hepatol Commun. 2024;8:e0499.","DOI":"10.1097\/HC9.0000000000000499"},{"key":"457_CR63","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3748\/wjg.v30.i25.3143","volume":"30","author":"R Borriello","year":"2024","unstructured":"Borriello R, Esposto G, Mignini I, Gasbarrini A, Zocco MA. Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: an unmet clinical need. World J Gastroenterol. 2024;30:3143\u20136.","journal-title":"World J Gastroenterol"},{"key":"457_CR64","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3748\/wjg.v30.i10.1393","volume":"30","author":"MH Zeng","year":"2024","unstructured":"Zeng MH, Shi QY, Xu L, Mi YQ. Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease. World J Gastroenterol. 2024;30:1393\u2013404.","journal-title":"World J Gastroenterol"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00457-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00457-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00457-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:02:47Z","timestamp":1792429367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00457-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1038\/s41387-026-00457-3","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"50"}}